Kaplan-Meier plotter analysis demonstrated that high IFI6 expression correlated with poor prognosis in breast cancer patients with ER-positive, PR-positive, HER2-positive, and lymph node-positive subtypes. Here, ERBB2 is linked to breast cancer.